Skip Navigation


NDT Advance Access originally published online on November 11, 2006
Nephrology Dialysis Transplantation 2007 22(1):59-63; doi:10.1093/ndt/gfl643
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/1/59    most recent
gfl643v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Segall, L.
Right arrow Articles by Covic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segall, L.
Right arrow Articles by Covic, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis

Liviu Segall and Adrian Covic

Nephrology, Dialysis and Renal transplantation Center ‘Dr C. I. Parhon’ University Hospital, Iasi, Romania

Correspondence and offprint requests to: Prof. Dr Adrian Covic, Clinica a IV-a Medicala-Nefrologie, Spital ‘Dr C. I. Parhon’, B-dul Carol I nr. 50, Iasi 700503, Romania. Email: acovic@xnet.ro

Keywords: congestive heart failure; haemodialysis; peritoneal dialysis

The first 150 words of the full text of this article appear below.

In end-stage renal disease (ESRD) patients, congestive heart failure (CHF) is a dreadful complication. Its pathogenesis is multifactorial. Chronic arterial hypertension, uraemic cardiomyopathy, coronary artery disease (CAD) and valvular disease all lead to myocardial damage that may eventually result in CHF. Other more or less well-proven contributory factors are chronic volume overload, anaemia, metabolic acidosis, secondary hyperparathyroidism, the malnutrition-inflammation complex syndrome and the haemodialysis (HD) arterio-venous fistula (AVF).

In the Dialysis Outcomes and Practice Patterns Study (DOPPS), the prevalence of CHF in the HD population was reported to be 46% in the US, but only 25% in Europe and as little as 6% in Japan [1]. Such substantial geographical differences may be explained in part by the fact that the US patients were older and had more diabetes, CAD and other vascular diseases than the European and Japanese patients, but they may also derive from different criteria for . . . [Full Text of this Article]



   What do we learn from survival studies?
 
The study of Stack et al.
Other studies


   Influence of dialysis modality on CHF risk factors
 


   Heart changes and the risk of developing CHF during dialysis
 


   Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. Krajewska, W. Kosmala, W. Weyde, K. Madziarska, T. Porazko, W. Kopec, R. Klak, J. Penar, M. Kusztal, E. Watorek, et al.
The effect of dialysis modality (PD and HD) on cardiac morphology and functions in chronic kidney disease patients at very high cardiovascular risk
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 768 - 769.
[Full Text] [PDF]